Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Feb;27(2):348-351.
doi: 10.3201/eid2702.203439.

Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020

Multicenter Study

Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020

Lucila M Carosella et al. Emerg Infect Dis. 2021 Feb.

Abstract

An epidemic of dengue virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infections occurred in Argentina during 2020. We describe the clinical characteristics and outcomes in a cohort of patients hospitalized because of co-infection. We retrospectively identified 13 patients from different hospitals in Buenos Aires who had confirmed infection with SARS-CoV-2 and dengue virus and obtained clinical and laboratory data from clinical records. All patients had febrile disease when hospitalized. Headache was a common symptom. A total of 8 patients had respiratory symptoms, 5 had pneumonia, and 3 had rash. Nearly all patients had lymphopenia when hospitalized. No patients were admitted to an intensive care unit or died during follow up. Co-infection with SARS-CoV-2 and dengue virus can occur in patients living in areas in which both viruses are epidemic. The outcome of these patients did not seem to be worse than those having either SARS-CoV-2 or dengue infection alone.

Keywords: Argentina; Buenos Aires; COVID-19; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; co-infection; coronavirus disease; coronaviruses; dengue fever; dengue virus; respiratory infections; viruses; zoonoses.

PubMed Disclaimer

Comment in

  • SARS-CoV-2 and Dengue virus co-infection: A case from North Caribbean Colombia.
    Villamil-Gómez WE, Rojas-Torres I, Perea-Vásquez LE, Collazos-Torres LA, Murillo-Moreno MA, Morales-Rudas JD, Pagani N, Rodriguez-Morales AJ, Paniz-Mondolfi AE. Villamil-Gómez WE, et al. Travel Med Infect Dis. 2021 Sep-Oct;43:102096. doi: 10.1016/j.tmaid.2021.102096. Epub 2021 Jun 3. Travel Med Infect Dis. 2021. PMID: 34091012 Free PMC article. No abstract available.

References

    1. Ministry of Health. Argentina. Daily reported [in Spanish] [cited 2020 Oct 26]. https://www.argentina.gob.ar/coronavirus/informes-diarios/reportes/octub...
    1. Weekly Epidemiological Bulletin. Autonomous city of Buenos Aires [in Spanish] [cited 2020 Nov 17]. https://www.buenosaires.gob.ar/sites/gcaba/files/bes_200_se_23_vf.pdf
    1. Bicudo N, Bicudo E, Costa JD, Castro JALP, Barra GB. Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge. Braz J Infect Dis. 2020;24:452–4. 10.1016/j.bjid.2020.07.008 - DOI - PMC - PubMed
    1. Epelboin L, Blondé R, Nacher M, Combe P, Collet L. COVID-19 and dengue co-infection in a returning traveller. J Travel Med. 2020;27:taaa114. - PMC - PubMed
    1. Pontes RL, de Brito BB, da Silva FAF, Figueredo MS, Correia TML, Teixeira AF, et al. Coinfection by SARS-CoV-2 and dengue virus in a dual viral circulation setting. Travel Med Infect Dis. 2020;37:101862. 10.1016/j.tmaid.2020.101862 - DOI - PMC - PubMed

Publication types